Methods: C57BL/6 mice bearing orthotopic KPC pancreatic tumors were treated with a novel immune checkpoint inhibitor (VISTA-blocking antibodies), a vaccine (mutant KRASG12D peptide with TLR7/8/9 agonists), or a combination of both. This evidence concerns the gene TLR7 and pancreatic neoplasm.